TELESTA THERAPEUTICS INC T.TST

Euro Pacific's upgrade to $1.70 - anyone have the report?

[somweyungguy]

Please share with the class.

Sqr

PS - an absolute pleasure to have "Beech" back

[somweyungguy]

They should do somthin bout that BNHLF US symbol I mean really...an obsolete symbol under the old company name trading on what amount to a "casino like" OTC listing.... Sounds hard to believe management "isn't aware" of this rather "poor corporate" decision. Comments? Beech? sqr

[somweyungguy]

Thoughts? Is this report on the company website? Has the M partners target "leaked yet" Squire

[investderp]

1) Why should they pay to change the OTC listing symbol?  People would grumble at them throwing money away. 2) Why should they pay change their OTC listing, when it will possibly be "upgraded" to a NASDAQ listing in the future, when they could change it then?

[HighteawithIntrepid]

I would agree that a Nasdaq listing would remove the need for any  immediate change. It is my understanding that the consolidation is a "if it makes sense" if you read the entire document this is lot clearer than the first blush reference in agenda item 5. But maybe it should be amended as a 2 parter. If we get a FDA thumbs up and it is a condition of the listing then yes. so a

[somweyungguy]

Hey apoloigist......you write like a "friend of ours" ; - ) Have a look at the US "BNHLF" casino listing It's running 85% short and 40% the last two days. We announce a GLOBAL deal for our lead product and HAVE ZERO US exposure and give away 35% of our company at .34 8 days before A+ FDA news? This thing is GONNA fly bro..but spare us the Shakespearian "two man

[investderp]

I'm not sure what you want me to see with the listing.  Can you hold my hand and spell my name wrong too? Because a closing price of $0.3552 USD is still $0.47 CAD.  

[rbc123]

Telesta Therapeutics has 347% upside, says Euro Pacific October 28, 2015 By Nick Waddell 0 Comments ipsenA new partnership has Euro Pacific Canada analyst Doug Loe feeling bullish about Telesta Therapeutics (TSX:TST). This morning, Telesta announced it had entered into an exclusive licensing agreement with French pharmaceutical company Ipsen to develop and commercialize MCNA for the treatment of